(Q43201126)

16 November 2017

Can a rational design for metronomic chemotherapy dosing be devised? (English)

1 reference

16 November 2017

1 reference

Maraveyas A

1

1 reference

16 November 2017

Lam T

series ordinal

2

1 reference

16 November 2017

Hetherington JW

series ordinal

3

1 reference

16 November 2017

Greenman J

series ordinal

4

1 reference

16 November 2017

language of work or name

English

0 references

publication date

1 April 2005

1 reference

British Journal of Cancer

16 November 2017

1 reference

16 November 2017

92

1 reference

16 November 2017

8

1 reference

16 November 2017

1588-1590

1 reference

The anti-angiogenic basis of metronomic chemotherapy

16 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362004

Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362004

The biology and clinical uses of blood stem cells.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362004

Maximum tolerable dose and low-dose metronomic chemotherapy have opposite effects on the mobilization and viability of circulating endothelial progenitor cells.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362004

15 August 2018

Identifiers

DOI

10.1038/SJ.BJC.6602474

1 reference

16 November 2017

1 reference

16 November 2017

PubMed publication ID

15846302

1 reference